The influence of kynurenine and its metabolites on lipid metabolism

Pteridines

Volumn 8, Issue 3, 1997, Pages 201-205

  Rudzite, Vera ^b   Jurika, Edite ^b   Jirgensons, Janis ^b   Herpfer, Inga ^a   Weiss, Günter ^a   Wachter, Helmut ^a   Fuchs, Dietmar ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b University of Innsbruck ^*

Author keywords

3 Hydroxyanthranilic acid and Quinolinic acid; 3 Hydroxykynurenine; Cholesterol; Fatty acids; Kynurenine; Phospholipids

Indexed keywords

3 HYDROXYANTHRANILIC ACID; 3 HYDROXYKYNURENINE; ARACHIDONIC ACID; FATTY ACID; KYNURENINE; LINOLEIC ACID; OLEIC ACID; PALMITIC ACID; PHOSPHOLIPID; QUINOLINIC ACID; STEARIC ACID;

ANIMAL TISSUE; ARTICLE; CELL MEMBRANE FLUIDITY; CONTROLLED STUDY; FATTY ACID METABOLISM; LIPID COMPOSITION; LIVER METABOLISM; MALE; NONHUMAN; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030722870     PISSN: 09334807     EISSN: 21954720     Source Type: Journal    
DOI: 10.1515/pteridines.1997.8.3.201     Document Type: Article

References (27)

1. Rudzite V, Jurika E, Baier-Bitterlich G, Wachter H, Fuchs D. Effect of sepiapterin, 7,8-dihydrobiopterin, 5,6,7,8-tetrahydrobiopterin and xanthopterin on cholesterol and phospholipid content and phospholipid biosynthesis in vitro. Pteridines 1995; 6: 69-73.
2. Rudzite V, Jurika E, Baier-Bitterlich G, Wachter H, Fuchs D. Effect of 7,8-dihydroneopterin, biopterin and isoxanthopterin on cholesterol and phospholipid content and phospholipid biosynthesis in vitro. Pteridines 1996; 7: 24-28.
3. Rudzite V, Jurika E, Reibnegger G, Weiss G, Wachter H, Fuchs D. Influence of kynurenine, neopterin, noradrenalin and pyridoxal-5-phosphate on cholesterol and phospholipid content and phospholipid biosynthesis in vitro. Pteridines 1993; 4: 126-130.
4. Rudzite V, Jurika E, Fuchs D, Baier - Bitterlich G, Wachter H. Kynurenine and pteridines in changes of membrane fluidity. Adv Exp Med Biol 1996; 398: 255-261.
5. Ostro M J, Bessinger B, Summers J, Dray S. Effect of membrane lipid composition on mobility of lymphocyte surface immunoglobulins. In: Membrane Fluidity. Biochemical Techniques and Cellular Regulation. Kates M and Kuksis A, eds., The Humana Press Inc., Clifton, New Jersey,1980, 105-117.
6. Ferber E, Krner E, Schmidt B, Fischer H, Peskar BA, Anders C. Dynamics of membrane fatty acids during lymphocyte stimulation by mitogens. In: Membrane Fluidity. Biophysical Techniques and Cellular Regulation. Kates M and Kuksis A, eds., The Humana Press Inc., Clifton, New Jersey, 1980; 239-263.
7. Cloete F, de Waal J M, Badenhorst P W, Kelderman M. Abnormal fatty acid composition of plasma and platelets in patients with acute myocardial infarction. In: Abstracts of 1st International Congress "Fatty Acids and Lipids from Cell Biology to Human Disease". Lugano, Switzerland, 1993; 109.
8. Olivieri O, Stanzial AM, Girelli D, et al. Selenium status, fatty acids, antioxidant vitamins and aging. The nove study. In: Abstract of 1st International Congres "Fatty Acids and Lipids from Cell Biology to Human Disease". Lugano, Switzerland, 1993; 136.
9. Rudzite V, Jurika E. Kynurenine and lipid metabolism. Adv Exp Med Biol 1991; 294: 463-466.
10. Rudzite V, Sileniece G, Jirgensons J, et al. The significance of increased kynurenine level in blood to the development of cardiovascular pathology. Acta Medica Baltica, 1994, 1: 4-19.
11. Rudzite V. Tryptophan. Leningrad: Medicina, 1973.
12. Lapin I P. Kynurenine and anxiety. Adv Exp Med Biol 1996; 398: 191-194.
13. Guzeva VI, Mikhailov ÏB, Melnikova NV. The kynurenines and seizures. Adv Exp Med Biol 1996; 398: 263-264.
14. Rudzite V, Jurika E, Fuchs D, Reibnegger G, Wachter H. The influence of kynurenine, neopterin and pyridoxal-5-phosphate /P-S-P/ on cholesterol content and phospholipid biosynthesis in vitro. In: L-Tryptophan Current Prospects in Medicine and Drug Safety. Kochen W and Steinhart H, eds., Walter de Gruyter, Berlin-New York,1994; 165-170.
15. Folch J, Lees M, Stanley GH. A simple method for isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226: 495-509.
16. Predtetchenski VJ, Borovskaja VM, Margolina LT. Handbook of Clinical and Laboratory Investigation. Moscow: Medgjz 1950. /Russ./.
17. Homolka J. Bestimmung des anorganischen Phosphors nach Urbach - Raabe /modifiziert/. In: Chemische Diagnostik im Kindersalter mit Bevorzugung der Mikrometrischen Blutanalysen. Berlin VEB: Verlag Volk und Gesundheit 1964; 354-355.
18. Kates M. Technique of Lipidology. Moscow: Mir, 1978; 201-203 /Russ./.
19. Weber E. Grundriss der biologischen Statistik fr Naturwissenschaftler, Landwirte und Mediziner. Jena: Gustav Fischer Verlag 1957.
20. Weiss G, Fuchs D, Hausen A, et al. Neopterin modulates toxicity mediated by reactive oxygen and chloride species. FEBS Lett 1993; 321: 89-92.
21. Reibnegger G, Fuchs D, Murr C, et al. Effects of pteridines on luminol-dependent chemiluminescence induced by chloramine-T. Free Radical Biol Med 1995; 18: 515-523.
22. 2. Biochim Biophys Acta 1993; 1156: 267-274.
23. Harwood HJ, Greene YJ, Stacpoole PW. Inhibition of human leukocyte 3-hydroxy-3-methyl-glutaryl-CoA reductase activity by ascorbic acid. An effect mediated by the free radical monodehydroascorbate. J Biol Chem 1986; 261: 7127-7135.
24. Fuchs D, Baier-Bitterlich G, Wede I, Wachter H. Reactive oxygen and apoptosis. In: Oxidative Stress and the Molecular Biology of Antioxidant Defenses. J Scandalios, ed., Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1997; 139-167.
25. Heyes MP, Saito K. Quinolinic acid and kynurenine pathway metabolism in neurological diseases. In: Ishiguro I, Kido R, Nagatsu T, Nagamura Y, Ohta Y, eds. Advances in Tryptophan Reasearch 1992. Fujita Health University Press, Toyoake, 1992; 95-96.
26. Heyes MP. The kynurenine pathway and neurologic disease. Therapeutic Strategies. Adv Exp Med Biol 1996; 398: 125-129.
27. Goda K, Kishimoto R, Shimizu S, Hamane Y, Ueda M. Quinolinic acid and active oxygens. Possible contribution of active oxygens during cell death in the brain. Adv Exp Med and Biol 1996; 398: 247-254.